^
Association details:
Biomarker:HPRT1 overexpression
Cancer:Oral Cancer
Drug:cisplatin (DNA synthesis inhibitor)
Direction:Resistant
Evidence:
Evidence Level:
Resistant: D – Preclinical
Title:

HPRT1 Promotes Chemoresistance in Oral Squamous Cell Carcinoma via Activating MMP1/PI3K/Akt Signaling Pathway

Published date:
02/09/2022
Excerpt:
We found that highly expressed HPRT1 was associated with a poor prognosis and could promote resistance to cisplatin (CDDP) in OSCC cells in both in vitro and in vivo.
DOI:
10.3390/cancers14040855